COVID-19

Vaccine Trials Starts Round The World: All You Need to Know

Published

3 years ago

April 24, 2020

GiftUgbede

Thanks to big governmental organizations, volunteers, healthworkers, scientists, virologist, and each countries government in developing a vaccine for the deadly virus (COVID-19)

Massive Speed has been injected for a world-wide solution to the COVID-19 Pandemic

All Known Facts About Vaccine Trials on COVID-19

On COVID-19 Vaccine Trials – Thanks to big governmental organizations, volunteers, health workers, scientists, virologists, and each countries government in developing a vaccine for the deadly virus (COVID-19).

The wait for a vaccine that could cure coronavirus might take 12 to 18 months.

Much speed has been injected towards getting a solution, news around the world now centres on a way out which is a vaccine.
In medical terms, before vaccine approval, Vaccine Trials is first conducted and approved before mass production follows

Facts About COVID-19 Vaccine Trials on Human

UK Begins Vaccine Trials This Week

According to Euronews, the beginning of UK clinical trials this week to find a coronavirus vaccine coincides with the start of World Immunization Week.
BioNTech and its partner Pfizer have been received approval from the Paul-Ehrlich-institure to begin testing a variety of experimental vaccines on 200 healthy colunteers aged 18 and 55.

“This is a good signal that the development of a vaccine in Germany has progressed enough to start the first studies,” said Health Minister Jens Spahn.

Official Statement Reads “A team at Oxford University began clinical trials on April 23, with tests to be carried out on 1,112 people who will be divided into two groups. Scientists want to stimulate the immune system to attack the virus.”

“Remdesivir” Fails First Trial

Do You know Remdesivir?

Remdesivir is an antiviral medication

It’s was actually the reigning champion in the fight against COVID-19 as claimed in some countries that when admitted, it makes the carrier get well sooner.

STOCK PHOTO OF REMDESIVIR, ANTIVIRAL DRUG

But a Chinese trial showed that the drug had not been successful. Dashing all hopes of a solution to coronavirus. This was found in the draft documents accidentally published by the World Health Organization

Bottom Line

The drug did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, it said

The University of Oxford begins Clinical trials for coronavirus vaccine

The first patients have been enrolled in human trials for a coronavirus vaccine at the historic University of Oxford after the U.K’s Health Secretary said the country would be “throwing everything” behind the project.

PERTH, AUSTRALIA – APRIL 20: Registered nurse Heather Hoppe receives a flu vaccination in the trial clinic at Sir Charles Gairdner hospital on April 20, 2020 in Perth, Australia. Healthcare workers in Western Australia are participating in a new trial to test whether an existing tuberculosis vaccine can help reduce their chances of contracting COVID-19.

The clinical trial will test the effects of possible COVID-19 treatments and start the process of vaccine evaluation in the university’s first human studies.

The UK, Germany start vaccine trial; Indian Pharma will also play a big role

Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials on humans that have been approved across the globe.

Indian pharmaceutical companies, well-known for producing affordable low-cost medicines, will play an important role in the global fight against the coronavirus pandemic.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19.

Clinical tests go ahead in China and across the globe to find a cure for the deadly Covid-19 disease

China scientists believe they are one step closer to a breakthrough in the race to immunize the human race against the deadly COVID-19 disease.

Earlier this week, it was revealed that a team lead by Qin Chuan at China’s National Institutes for Food and Drug Control in Beijing has started human testing in Xuzhou, a major city in Jiangsu province.

“Preclinical tests on non-human primates found that when given at a sufficient dose, the vaccine could provide protection against Sars-CoV-2, [which causes Covid-19],’” a preliminary paper said after being released by the research group on medRxiv.org and reported by the Chinese media.

USAsk VIDO-InterVac has awarded #24 million for COVID-19 Vaccine research

“This major federal investment will accelerate VIDO-InterVac’s efforts to develop a Canadian vaccine against COVID-19, critical work that will help protect the health and safety of all Canadians and people around the world,” said USask President Peter Stoicheff.

“This funding is a credit to the outstanding VIDO-InterVac team that is working tirelessly at the forefront of COVID-19 research, in collaboration with the World Health Organization, the Public Health Agency of Canada and researchers across Canada and around the world.”

Full Report Here

You can also Read:

More Updates Follows

COVID-19

PCR Tests for Travellers Fraudulent, Probe NCDC, Ministry – WHO Envoy

Published

2 years ago

March 18, 2022

Gift Wada

PCR Tests for Travellers Fraudulent, Probe NCDC, Ministry – WHO Envoy

The World Health Organisation’s Special Envoy for the Access to COVID-19 Tools Accelerator, Ayoade Alakija, has called for an investigation of the Nigeria Centre for Disease Control and the Ministry of Health over the required COVID-19 PCR tests for inbound passengers to Nigeria.

YOU CAN FOLLOW US ON FACEBOOK

Alakija, in a tweet via her official Twitter handle, @yodifiji, wondered why the PCR tests were done with no reagents.
According to reports, the Director General of the Nigeria Centre for Disease Control, Ifedayo Adetifa, had earlier insisted that Nigeria would not scrap COVID-19 tests for inbound passengers into the country.

Adetifa had said the country was reporting a high rate of COVID-19 cases from inbound passengers, hence the need for the insistence of the tests.
Alakija, reacting to a tweet by a journalist, David Hundeyin, tweeted, “It’s a scam. The entire thing is a criminal enterprise and should be exposed. “Diagnostic tests to enter a country where the government officials have interest in Dx test centres. PCR tests with no reagents? NCDC and MOH should be investigated. It is a scam, period.”

COVID-19

Austria Suspends Mandatory Covid-19 Vaccine Law

Published

2 years ago

March 9, 2022

Eunice Johnson

Austria has announced that it is suspending mandatory Covid-19 vaccinations for all adults this came weeks after the legislature took effect in an EU first.

YOU CAN FOLLOW US ON FACEBOOK

The Alpine nation of nine million people was among few countries in the world to make jabs against the coronavirus compulsory for all adults.
The law took effect in February and called for fines up to 3,600 euros ($3,940) from mid-March for those who do not comply.

However, minister Karoline Edtstadler said the law’s “encroachment of fundamental rights” could no longer be justified by the danger posed by the pandemic.
“After consultations with the health minister, we have decided that we will of course follow what the (expert) commission has said,” Edtstadler told reporters after a Cabinet meeting.
“We see no need to actually implement this compulsory vaccination due to the (Omicron) variant that we are predominantly experiencing here.” He noted

According to him,the highly-contagious variant is widely believed to be less severe than previous strains of the virus, and so far Austrian hospitals have been able to cope with a surge in cases.

COVID-19

F.G. Commences Vaccination with Over 30 Million J&J Vaccines

Published

2 years ago

February 25, 2022

Eunice Johnson

Following efforts to increase the COVID-19 vaccination coverage of eligible persons across the country, the Federal Government has launched the service delivery, communication, accountability, logistics, electronic reporting, and supportive supervision (S.C.A.L.E.S) strategy.

The SCALES 2.0 strategy, which will ensure that more Nigerians can easily locate a nearby health facility to get vaccinated by visiting the website (www.vacsitefinder.nphcda.gov.ng), will also integrate childhood immunisation alongside other primary health care services.

YOU CAN FOLLOW US ON FACEBOOK

Also, eligible persons can now get vaccinated with a single shot of the Johnson and Johnson (J&J) COVID-19 vaccines, as there are over 30 million vaccine doses available.

Nigeria has received over 64 million COVID-19 vaccines – AstraZeneca, Moderna, J&J and Pfizer. Furthermore, 48 million vaccines are expected before mid-year.

Latest vaccination data showed that as of February 21, 2022, a total of 17,199,853 eligible Nigerians have received their first dose of COVID-19 vaccination, while 7,663,560 have received their second dose. In total, 24,863,413 vaccine doses have been administered.

The Executive Director and Chief Executive Officer of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib, made this known in Abuja during the launch of the SCALES 2.0 strategy with the use of the single dose J&J vaccine.

Dr Shuaib said: “We want to ensure that we not only decentralise COVID-19 vaccination, but make sure that we improve coverage and access to COVID-19 vaccination. Today, we are vaccinating just a little over 200,000 people per day. For us to reach our target of reaching 70 per cent of eligible populations before the end of 2022, we have to hit 550,000 people per day. This will ensure that we reach herd immunity.

“We are also going to be launching the single shot vaccine (Johnson & Johnson) for everyone. We understand that one of the reasons there is a gap between our first and second doses is because people experience adverse events following COVID-19 vaccination. Although the adverse events are very mild, we know that the opportunity to have a single shot not only in the hardest to reach areas, but everybody having access to one single shot will definitely increase our coverage of COVID-19 vaccination.

“The COVID-19 vaccination ‘site finder’ will improve the ability of Nigerians to assess COVID-19 vaccines. If you are able to sign on to this website, you will be shown the nearest COVID-19 vaccination centre.”

In her remarks, the World Health Organization (WHO) Regional Director for Africa, Dr Moeti Matshidiso, hailed the Federal Government’s vaccination strategy and efforts in ensuring that more Nigerians are covered.

She said: “I think we have learnt many lessons on how to leverage the capacities and lessons in delivering such campaigns in a country like Nigeria and internationally.

“I understand that there is going to be a great deal of emphasis on decentralisation – on really leveraging the decentralised nature of the Nigerian system and government to engage decision makers at the state and local government level, so that they can drive the very much action needed to speed up delivery of vaccines to the population.

“There will also be the need to expand the delivery capacity because at the same time the country is carrying out this important work, there is other work of delivering vaccines, responding to public health emergencies going on.”

The Minister of Health, Dr Osagie Ehanire, added: “Let me assure Nigerians that we have adequate stock of the Johnson and Johnson vaccine, as we have over 30 million doses in stock. I call on all eligible persons that are yet to receive their vaccination to go to the nearest COVID-19 vaccination site and get vaccinated. This single dose offers the same protection you get from two doses of AstraZeneca, Pfizer Bio-N-Tech and Moderna vaccines.